Abstract
Pathophysiology of pre-eclampsia depends on a defective trophoblastic invasion of uteroplacental blood vessels that leads to placental ischemia and induction of an inflammatory process within the placenta. This process may trigger the expression of Cancer antigen 125 (CA 125), C-reactive protein (CRP) and uric acid (UA). This research aimed to evaluate the association of serum CA 125, CRP and uric acid with Preeclampsia. The study recruited 200 singleton Sudanese pregnant women, who were divided into three groups: controls (n = 100), mild preeclampsia (n = 46) and severe preeclampsia (n = 54). The study subjects were matched for maternal age, gestational age and body mass index. Blood samples were taken for measurement of the different variables using immune- assay and enzymatic automated chemical analysis. The levels of CA 125 in mild and severe preeclampsia were (21.94 +/- 0.749 IU/ml) and (40.78 +/- 1.336 IU/ml) respectively, which was significantly different (P<0.001) from the control mean (16.48 +/- 0.584 IU/ml). There was also a significant difference between the mean levels of CRP in mild and severe preeclampsia (15.17 +/- 0.788 mg/L), (31.50 +/- 1.709 mg/L) compared with controls (4.79 +/- 0.178 mg/L), (P<0.01). There was also a significant difference in the mean levels of UA in mild and severe cases (6.44 +/- 0.293 and7.37 +/- 0.272) in comparison with the controls (4.00 +/- 0.061); (P.001). There were significant differences between severe and mild groups (P.05). Cancer antigen 125, CRP and UA levelsleft-to-right mark correlated positively with mean arterial blood pressure (MAP) where (r >0.7; P < 0.001). ROC curve validates the utility of these biomarkers for monitoring preeclampsia (AUC >0.8; P < 0.001). In conclusion CA 125, CRP and UA were significantly higher in preeclampsia compared with the controls. The rise of the analytes was directly associated with the severity of the disease.